Mereo BioPharma Group (MREO) Competitors $1.96 -0.14 (-6.67%) Closing price 04:00 PM EasternExtended Trading$1.98 +0.02 (+0.82%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MREO vs. ATAI, TRML, CVAC, LENZ, CALT, ELVN, MAZE, DNTH, PRAX, and NUVBShould you be buying Mereo BioPharma Group stock or one of its competitors? The main competitors of Mereo BioPharma Group include atai Life Sciences (ATAI), Tourmaline Bio (TRML), CureVac (CVAC), LENZ Therapeutics (LENZ), Calliditas Therapeutics AB (publ) (CALT), Enliven Therapeutics (ELVN), Maze Therapeutics (MAZE), Dianthus Therapeutics (DNTH), Praxis Precision Medicines (PRAX), and Nuvation Bio (NUVB). These companies are all part of the "pharmaceutical products" industry. Mereo BioPharma Group vs. Its Competitors atai Life Sciences Tourmaline Bio CureVac LENZ Therapeutics Calliditas Therapeutics AB (publ) Enliven Therapeutics Maze Therapeutics Dianthus Therapeutics Praxis Precision Medicines Nuvation Bio atai Life Sciences (NASDAQ:ATAI) and Mereo BioPharma Group (NASDAQ:MREO) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends. Is ATAI or MREO more profitable? Mereo BioPharma Group's return on equity of -80.00% beat atai Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets atai Life SciencesN/A -85.43% -64.38% Mereo BioPharma Group N/A -80.00%-66.94% Which has more risk & volatility, ATAI or MREO? atai Life Sciences has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500. Comparatively, Mereo BioPharma Group has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Do analysts prefer ATAI or MREO? atai Life Sciences presently has a consensus target price of $11.25, indicating a potential upside of 120.59%. Mereo BioPharma Group has a consensus target price of $7.40, indicating a potential upside of 277.55%. Given Mereo BioPharma Group's higher probable upside, analysts plainly believe Mereo BioPharma Group is more favorable than atai Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score atai Life Sciences 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 2.86Mereo BioPharma Group 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.83 Do insiders & institutionals believe in ATAI or MREO? 28.4% of atai Life Sciences shares are held by institutional investors. Comparatively, 62.8% of Mereo BioPharma Group shares are held by institutional investors. 26.8% of atai Life Sciences shares are held by company insiders. Comparatively, 5.5% of Mereo BioPharma Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, ATAI or MREO? Mereo BioPharma Group has higher revenue and earnings than atai Life Sciences. Mereo BioPharma Group is trading at a lower price-to-earnings ratio than atai Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioatai Life Sciences$310K3,846.06-$149.27M-$0.69-7.39Mereo BioPharma Group$10M31.16-$43.25M-$0.07-28.00 Does the media favor ATAI or MREO? In the previous week, Mereo BioPharma Group had 2 more articles in the media than atai Life Sciences. MarketBeat recorded 4 mentions for Mereo BioPharma Group and 2 mentions for atai Life Sciences. atai Life Sciences' average media sentiment score of 1.33 beat Mereo BioPharma Group's score of 0.62 indicating that atai Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment atai Life Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mereo BioPharma Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMereo BioPharma Group beats atai Life Sciences on 8 of the 15 factors compared between the two stocks. Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MREO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MREO vs. The Competition Export to ExcelMetricMereo BioPharma GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$333.90M$3.31B$6.01B$10.23BDividend YieldN/A2.29%5.66%4.70%P/E RatioN/A22.1185.3526.57Price / Sales31.16420.52584.94179.70Price / CashN/A47.1938.3262.20Price / Book5.0310.2112.726.53Net Income-$43.25M-$52.40M$3.30B$275.96M7 Day Performance-3.92%0.88%1.05%-1.40%1 Month Performance10.11%12.35%7.56%5.16%1 Year Performance-52.43%30.13%79.69%31.55% Mereo BioPharma Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MREOMereo BioPharma Group2.2853 of 5 stars$1.96-6.7%$7.40+277.6%-49.3%$333.90M$10M0.0040News CoverageAnalyst ForecastATAIatai Life Sciences3.2891 of 5 stars$5.45+3.4%$11.25+106.4%+400.0%$1.23B$2.31M-7.9080Positive NewsAnalyst ForecastTRMLTourmaline Bio1.4539 of 5 stars$48.16+0.9%$45.65-5.2%+76.0%$1.23BN/A-14.0444Analyst ForecastCVACCureVac3.789 of 5 stars$5.35-0.4%$6.83+27.7%+85.9%$1.20B$579.18M5.57880News CoverageAnalyst ForecastLENZLENZ Therapeutics1.7555 of 5 stars$44.89+6.8%$49.60+10.5%+89.2%$1.20B$5M-23.63110News CoverageAnalyst ForecastCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180ELVNEnliven Therapeutics2.5061 of 5 stars$20.30+1.4%$41.20+103.0%-24.5%$1.19BN/A-10.1550Analyst ForecastInsider TradeMAZEMaze Therapeutics3.6962 of 5 stars$25.20-6.7%$33.83+34.3%N/A$1.18B$167.50M0.00121Analyst ForecastGap UpDNTHDianthus Therapeutics2.8808 of 5 stars$39.55+7.7%$61.57+55.7%+23.7%$1.18B$6.24M-12.1780Analyst ForecastPRAXPraxis Precision Medicines1.9846 of 5 stars$52.38-0.1%$85.56+63.3%-13.1%$1.10B$8.55M-4.26110Analyst ForecastNUVBNuvation Bio2.5928 of 5 stars$3.22+0.6%$7.50+132.9%+69.7%$1.10B$7.87M-5.1160Analyst Forecast Related Companies and Tools Related Companies ATAI Competitors TRML Competitors CVAC Competitors LENZ Competitors CALT Competitors ELVN Competitors MAZE Competitors DNTH Competitors PRAX Competitors NUVB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MREO) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
